Moneycontrol
HomeNewsBusinessLockdown 4.0 | ITC restarts production of cigarettes at its factories: Report
Trending Topics

Lockdown 4.0 | ITC restarts production of cigarettes at its factories: Report

The company, which has an over 75 percent share in the country's tobacco industry, had suspended production of cigarettes at its factories following the announcement of a nationwide lockdown in March

May 18, 2020 / 21:55 IST
Story continues below Advertisement

Cigarette-maker ITC has restarted production at some of its cigarette factories, The Economic Times reported. The company, which has an over 75 percent share in the country's tobacco industry, had suspended production of cigarettes at its factories following the announcement of a nationwide lockdown in March.

The price of cigarettes rose sharply in the grey market during the ongoing lockdown as most retailers began selling their stocks at almost double the price.

Story continues below Advertisement

As per the report, ITC is progressively reopening its cigarette factories.

On May 16, the company in an exchange filing said it has resumed operations at its factories and plant locations manufacturing non-essential items with a limited workforce. Its units engaged in the production of essential items continue to operate as per the earlier directives, it noted.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show